Status:
COMPLETED
Epidemiological Study of the Covid-19 Presto Test - The "COVIDOR" Study
Lead Sponsor:
Raphael Serreau
Collaborating Sponsors:
François Rabelais University
Assistance Publique - Hôpitaux de Paris
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18-65 years
Brief Summary
The "COVIDOR" epidemiological study. Our study would be the first at the community level in Orleans Métropole, aiming to determine the link between a positive IgM level on the serological test and a h...
Detailed Description
The metropolitan area of Orléans Métropole has 6,700 agents divided into 250 different trades and consequently multiple exposures and risks. The global covid-19 pandemic has affected France and the L...
Eligibility Criteria
Inclusion
- All the agents of the 3 local authorities (Loire Valley Region, CCTVL and Orléans Métropole) being voluntary to be tested for the COVID-PRESTO® test COVID-19 IgG / IgM rapid test (whole blood / serum / plasma) - Cassette
- Volunteer to get tested
Exclusion
- Opposition to the participation of the study
- Covid-19 disease
Key Trial Info
Start Date :
August 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 4 2021
Estimated Enrollment :
3228 Patients enrolled
Trial Details
Trial ID
NCT04387968
Start Date
August 24 2020
End Date
October 4 2021
Last Update
October 5 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Unité de Recherche PARADICT-O - Orléans
Orléans, France, 45000
2
Unité de Recherche PARADICT-O - Service de Médecine - Orléans Métropole
Orléans, France, 45000